• E-mailcarol.kamya@uib.no
  • Visitor Address
    Alrek helseklynge
    Årstadveien 17
  • Postal Address
    Postboks 7804
    5020 Bergen

Ms. Kamya is a health economist with a background in public health.  She has keen interest in immunisation and malaria research and implementation science. Ms Kamya has a decade of experience providing technical expertise in economic evaluation, health system research, monitoring, evaluation, and learning. 


Kamya, C., Abewe, C., Waiswa, P., Asiimwe, G., Namugaya, F., Opio, C., Ampeire, I., Lagony, S. and Muheki, C., 2021. Uganda’s increasing dependence on development partner’s support for immunization–a five year resource tracking study (2012–2016). BMC Public Health, 21(1), pp.1-11.

Kamya, C., Shearer, J., Asiimwe, G., Carnahan, E., Salisbury, N., Waiswa, P., Brinkerhoff, J. and Hozumi, D., 2017. Evaluating global health partnerships: a case study of a Gavi HPV vaccine application process in Uganda. International journal of health policy and management, 6(6), p.327.

Kamya, C., Namugaya, F., Opio, C., Katamba, P., Carnahan, E., Katahoire, A., Nankabirwa, J., Okiring, J. and Waiswa, P., 2022. Coverage and Drivers to Reaching the Last Child With Vaccination in Urban Settings: A Mixed-Methods Study in Kampala, Uganda. Global Health: Science and Practice, 10(4).

Carnahan, E., Gurley, N., Asiimwe, G., Chilundo, B., Duber, H.C., Faye, A., Kamya, C., Mpanya, G., Nagasha, S., Phillips, D. and Salisbury, N., 2020. Lessons Learned From Implementing Prospective, Multicountry Mixed-Methods Evaluations for Gavi and the Global Fund. Global Health: Science and Practice, 8(4), pp.771-782.

Shelley, K.D., Kamya, C., Mpanya, G., Mulongo, S., Nagasha, S.N., Beylerian, E., Duber, H.C., Hernandez, B., Osterman, A., Phillips, D.E. and Shearer, J.C., 2020. Partnership and Participation—A Social Network Analysis of the 2017 Global Fund Application Process in the Democratic Republic of the Congo and Uganda. Annals of Global Health, 86(1)

Mvundura M., Kiyaga C., Metzler M., Kamya C., Lim J., Sebuguzi C.M., Coffey P. Cost of screening for sickle cell disease using isoelectric focusing with dried blood spot samples in Uganda and estimation of price thresholds for a point-of-care-test.Journal of Blood Medicine 2019:10 1-9.

Nabirye, J., Okwi, L.A., Nuwematsiko, R., Kiwanuka, G., Muneza, F., Kamya, C. and Babirye, J.N., 2020. Health system factors influencing uptake of Human Papilloma Virus (HPV) vaccine among adolescent girls 9-15 years in Mbale District, Uganda. BMC Public Health, 20(1), pp.1-11.

Dwyer L.L.,Squires E., Teeple S., Ikilezi G., Roberts A.,  Colombara DV, Allen SK, Kamande SM, Graetz N, Flaxman AD,  Bcheraoui EL, Asbjornsdottir K., Asiimwe G, Augusto A.,, Augusto A.,  deSchacht C., Gimbel S., Kamya C, Namugaya F.,Masiye F., Mauieia  C., Miangotar Y., Mimche H.,  Sabonete A., Sherr H, Simuyemba M, Chisha A., Jasim S., Wagenaar B., Lim S.S. Small area estimation of under-5 mortality in Bangladesh, Cameroon, Chad, Mozambique, Uganda and Zambia using spatially misaligned data. Population Health Metrics. 2018. 16:13. https://doi.org/10.1186/s12963-018-0171-7

Opio C, Malumba R, Kagaayi J.,, Mukose A, Adoke Y, Muneza F, Kamya C and Waiswa P., Survival Time And Its Predictors Among Preterms In The Neonatal Period Post Discharge From Six Hospitals In Eastern Uganda Between June To July 2017.   Pub-Med



Ms Kamya's PHD work is centered around the economic evaluation of malaria chemoprevention alternatives in children with sickle cell anemia in eastern and Souther Africa. Specifically, she will be exploring the economic burden, health related quality of life and cost effectivness of dihydroartemisinin-piperaquine compared to sulphadoxine-pyrimethamine for chemoprevention of malaria in chidlren with sickle cell anemia.